Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic Publisher Pubmed

Ghajarzadeh M¹ ; Mirmosayyeb O^{1, 2, 3} ; Barzegar M^{2, 3} ; Nehzat N^{1, 3} ; Vaheb S³ ; Shaygannejad V^{2, 3} ; Maghzi AH⁴

Source: Multiple Sclerosis and Related Disorders Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Characteristics of Covid-19 Disease in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)

2. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)

3. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)

Experts (# of related papers)

View all Related Experts

Vahid Shaygannejad (5)

Fereshteh Ashtari (2)

Other Related Docs

4. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)

5. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)

6. A Multi-Centre Longitudinal Study Analysing Multiple Sclerosis Disease-Modifying Therapy Prescribing Patterns During the Covid-19 Pandemic, Journal of Neurology (2024)

7. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)

8. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)

Style	Citing Format
MLA	Ghajarzadeh M, et al.. "Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic." Multiple Sclerosis and Related Disorders, vol. 43, no. , 2020, pp. -.
APA	Ghajarzadeh M, Mirmosayyeb O, Barzegar M, Nehzat N, Vaheb S, Shaygannejad V, Maghzi AH (2020). Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic. Multiple Sclerosis and Related Disorders, 43(), -.
Chicago	Ghajarzadeh M, Mirmosayyeb O, Barzegar M, Nehzat N, Vaheb S, Shaygannejad V, Maghzi AH. "Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic." Multiple Sclerosis and Related Disorders 43, no. (2020): -.
Harvard	Ghajarzadeh M et al. (2020) 'Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic', Multiple Sclerosis and Related Disorders, 43(), pp. -.
Vancouver	Ghajarzadeh M, Mirmosayyeb O, Barzegar M, Nehzat N, Vaheb S, Shaygannejad V, et al.. Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic. Multiple Sclerosis and Related Disorders. 2020;43():-.
BibTex	@article{ author = {Ghajarzadeh M and Mirmosayyeb O and Barzegar M and Nehzat N and Vaheb S and Shaygannejad V and Maghzi AH}, title = {Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic}, journal = {Multiple Sclerosis and Related Disorders}, volume = {43}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Ghajarzadeh M AU - Mirmosayyeb O AU - Barzegar M AU - Nehzat N AU - Vaheb S AU - Shaygannejad V AU - Maghzi AH TI - Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic JO - Multiple Sclerosis and Related Disorders VL - 43 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract